• Raised the hypothesis that 'TIM', a pivotal enzyme in cellular glycolysis, functions as a 'quantum logic gate' beyond a simple chemical catalyst. • Elucidated that upon the occurrence of quantum decoherence, methylglyoxal, a toxic substance causing diabetic complications, is produced. • Reinterpreted the root cause of metabolic diseases as a 'failure of quantum interference', and demonstrated the protective effects of SGLT2 inhibitors through a quantum model. [Quantum Biology Society] Groundbreaking research results have emerged suggesting that metabolic enzymes, which generate energy in our bodies, operate not merely as simple chemicals, but like 'quantum logic gates', the computational units of quantum computers. Recently, a paper titled "Triosephosphate Isomerase as a Quantum Logic Gate: Could quantum decoherence be toxic?" was published on bioRxiv, a preprint repository for biology. This study is drawing extraordinary attention from the medical community by reinterpreting the pathogenesis of diseases from a quantum mechanical perspective, going beyond classical biochemistry. ■ A Key Enzyme in Life Phenomena Operates as a 'Quantum Logic Gate' The research team focused on the operational mechanism of 'triosephosphate isomerase (TIM)', a pivotal enzyme in cellular glycolysis that breaks down glucose into energy. The researchers modeled the precise proton transfer process occurring within the enzyme as a 'quantum tunneling' action rather than a simple chemical catalytic reaction. This is an unconventional hypothesis that the TIM enzyme functions like a 'quantum logic gate', the fundamental unit of a quantum computer, to control the conversion of substances with extreme precision. ■ Quantum Errors (Decoherence) Create 'Toxicity' The most surprising discovery is what happens when inefficiencies arise due to the so-called 'quantum decoherence' phenomenon during this quantum tunneling process. The study showed that when an error occurs in the computation (catalysis) as the quantum state breaks down, a fatal toxic byproduct called 'methylglyoxal' is produced instead of normal metabolites, inducing the formation of advanced glycation end products (AGEs) that cause diabetic complications. In other words, a 'quantum mechanical malfunction' (failure of quantum tunneling) of metabolic enzymes in cells can be the direct cause of metabolic disease complications. ■ The Efficacy of the Diabetes Drug 'SGLT2 Inhibitors' Proven by a Quantum Model... A New Paradigm in Drug Development Furthermore, the research team developed a mathematical quantum model of how 'SGLT2 inhibitors', a widely used diabetes treatment, protect the body. As a result of simulation analysis through a Python script, it was confirmed that this drug exerts a protective effect on vascular and renal cells by lowering the probability of the formation of the toxic intermediate (methylglyoxal). This approach is highly significant in that it reinterpreted the root cause of metabolic diseases, including diabetes, as a problem at the level of 'quantum interference' rather than a simple chemical imbalance. This research, which identified the causes of diseases from a quantum mechanical perspective and theoretically proved the efficacy of drugs, is expected to provide a strong foundation for the development of new metabolic disease drugs with novel mechanisms that fundamentally block the generation of toxic byproducts in the future.
• Raised the hypothesis that 'TIM', a pivotal enzyme in cellular glycolysis, functions as a 'quantum logic gate' beyond a simple chemical catalyst. • Elucidated that upon the occurrence of quantum decoherence, methylglyoxal, a toxic substance causing diabetic complications, is produced. • Reinterpreted the root cause of metabolic diseases as a 'failure of quantum interference', and demonstrated the protective effects of SGLT2 inhibitors through a quantum model. [Quantum Biology Society] Groundbreaking research results have emerged suggesting that metabolic enzymes, which generate energy in our bodies, operate not merely as simple chemicals, but like 'quantum logic gates', the computational units of quantum computers. Recently, a paper titled "Triosephosphate Isomerase as a Quantum Logic Gate: Could quantum decoherence be toxic?" was published on bioRxiv, a preprint repository for biology. This study is drawing extraordinary attention from the medical community by reinterpreting the pathogenesis of diseases from a quantum mechanical perspective, going beyond classical biochemistry. ■ A Key Enzyme in Life Phenomena Operates as a 'Quantum Logic Gate' The research team focused on the operational mechanism of 'triosephosphate isomerase (TIM)', a pivotal enzyme in cellular glycolysis that breaks down glucose into energy. The researchers modeled the precise proton transfer process occurring within the enzyme as a 'quantum tunneling' action rather than a simple chemical catalytic reaction. This is an unconventional hypothesis that the TIM enzyme functions like a 'quantum logic gate', the fundamental unit of a quantum computer, to control the conversion of substances with extreme precision. ■ Quantum Errors (Decoherence) Create 'Toxicity' The most surprising discovery is what happens when inefficiencies arise due to the so-called 'quantum decoherence' phenomenon during this quantum tunneling process. The study showed that when an error occurs in the computation (catalysis) as the quantum state breaks down, a fatal toxic byproduct called 'methylglyoxal' is produced instead of normal metabolites, inducing the formation of advanced glycation end products (AGEs) that cause diabetic complications. In other words, a 'quantum mechanical malfunction' (failure of quantum tunneling) of metabolic enzymes in cells can be the direct cause of metabolic disease complications. ■ The Efficacy of the Diabetes Drug 'SGLT2 Inhibitors' Proven by a Quantum Model... A New Paradigm in Drug Development Furthermore, the research team developed a mathematical quantum model of how 'SGLT2 inhibitors', a widely used diabetes treatment, protect the body. As a result of simulation analysis through a Python script, it was confirmed that this drug exerts a protective effect on vascular and renal cells by lowering the probability of the formation of the toxic intermediate (methylglyoxal). This approach is highly significant in that it reinterpreted the root cause of metabolic diseases, including diabetes, as a problem at the level of 'quantum interference' rather than a simple chemical imbalance. This research, which identified the causes of diseases from a quantum mechanical perspective and theoretically proved the efficacy of drugs, is expected to provide a strong foundation for the development of new metabolic disease drugs with novel mechanisms that fundamentally block the generation of toxic byproducts in the future.
• Published on bioRxiv, presenting a biophysical hypothesis that models triosephosphate isomerase (TIM), an enzyme essential for cellular glucose metabolism, as a quantum logic gate. • Predicted through a quantum mechanical model that SGLT2 inhibitors (SGLT2i), a diabetes treatment, reduce the probability of quantum decoherence in the TIM enzyme reaction. • Pioneering a new research frontier of quantum pharmacology by preventing the production of methylglyoxal, a cytotoxic byproduct, through the suppression of decoherence. [Quantum Biology Society] Groundbreaking biophysical research has been published revealing that an enzyme essential for cellular glucose metabolism (glycolysis) virtually operates like a quantum logic gate, the computational unit of a quantum computer. Going beyond classical biochemistry, this is a milestone achievement interpreting the human protective mechanisms of metabolic disease treatments from the perspective of subatomic quantum information processing. A paper titled "Triosephosphate Isomerase as a Quantum Logic Gate: Could quantum decoherence be toxic?" was released on the preprint repository bioRxiv. A joint research team of Daniele Romanello, a physician in Internal Medicine at Ospedale San Pietro Fatebenefratelli in Rome, Italy, and Andrea Romanello from the Department of Information Engineering at Sapienza University of Rome proposed this innovative quantum medical model. ■ Enzyme Catalysis Interpreted as Quantum Computation The researchers focused on the catalytic process of triosephosphate isomerase (TIM), a key enzyme in glycolysis, converting dihydroxyacetone phosphate (DHAP) to glyceraldehyde-3-phosphate (G3P). Instead of viewing this process merely as a classical "lock-and-key" model where specific molecular structures fit together, they remodeled it as a highly advanced quantum computational workflow involving precise proton transfer. This implies that enzymes in vivo act as logic circuits that autonomously control quantum states to derive specific biochemical outcomes. ■ SGLT2 Inhibitors Protect Cells by Preventing Quantum Decoherence What is even more interesting is that this quantum model interpreted the hidden human protective effects of sodium-glucose co-transporter 2 inhibitors (SGLT2i), which are widely prescribed as treatments for heart failure and diabetes. According to the model's predictions, if quantum decoherence occurs—where the enzyme loses its quantum state due to interference from the external environment during the metabolic process—it produces methylglyoxal, a toxic byproduct that destroys cells and strongly accelerates aging. As a result of the researchers' analysis, SGLT2i drugs were found to significantly reduce the probability of quantum decoherence in this TIM enzyme reaction. In other words, by suppressing the noise in the intracellular quantum computation process, the drug dramatically lowers the accumulation of the highly toxic substance methylglyoxal, ultimately exerting a powerful organ-protective effect. ■ The Prelude to the Era of Quantum Pharmacology This study holds great significance in that it reinterprets the pathogenesis of diseases and the mechanism of drug action beyond molecular chemical bonds, from the perspective of quantum coherence and dynamics. Experts anticipate that this approach will serve as an excellent starting point for quantum pharmacology, bringing a fundamental paradigm shift to the design of next-generation drugs for treating metabolic syndrome and degenerative diseases.
Abstract This study presents the hypothesis that triosephosphate isomerase (TIM), a pivotal enzyme in glycolysis, functions as a quantum logic gate. Utilizing quantum mechanics, we model TIM’s catalytic conversion of dihydroxyacetone phosphate (DHAP) to glyceraldehyde-3-phosphate (G3P) as a quantum operation involving precise proton transfer. To explore the broader implications of this quantum behavior, we developed a quantum model to assess the impact of Sodium-glucose co-transporter 2 inhibitors (SGLT2i) on methylglyoxal formation, a toxic byproduct linked to advanced glycation end products (AGEs). Our model predicts that SGLT2i could reduce methylglyoxal by decreasing the likelihood of intermediate formation, providing a potential mechanism for their protective effects observed in clinical contexts, including vascular and renal protection in diabetes, nephropathy, and heart failure. By reframing TIM as a quantum logic gate, this study not only challenges traditional views of enzymatic function but also opens new avenues for quantum biology, offering profound implications for the future of metabolic disease research and drug development. Moreover considering methylglyoxal as a result of a quantum tunnel inefficiency, it’s possible to hypothesize a new “noxa patogena” explicating it’s action as quantum interference.
A study published on bioRxiv demonstrated that quantum tunneling plays a key role in in vitro hydrolytic enzyme reactions by analyzing kinetic isotope effects (KIE) through deuterium substitution. The involvement of the quantum tunneling effect was confirmed through temperature dependence experiments in major biochemical reactions such as SIRT3-mediated deacetylation, I-SceI-mediated DNA cleavage, and caspase-3-mediated protein cleavage. By observing that DNA homologous recombinational (HR) repair in living cells is almost completely inhibited in a deuterium environment that lowers the probability of quantum tunneling, it was demonstrated that quantum effects dominate cell survival itself. [Quantum Biology Society] Behind life phenomena lies a strange quantum world that cannot be explained by classical mechanics. A prime example is quantum tunneling, where particles pass through reaction energy barriers as if by magic. While it has been known that quantum tunneling contributes to speeding up some enzyme reactions inside proteins , there has been a lack of concrete empirical evidence as to whether this is an essential physical requirement directly linked to actual cell survival. Recently, a groundbreaking study was published showing that if the quantum tunneling effect is inhibited, the cell's life support system itself completely halts. The paper titled "Cell viability is dominated by quantum effects," published on the preprint repository bioRxiv, strongly supports this. A multi-institutional joint research team, including Takeshi Yasuda from the National Institutes for Quantum and Radiological Sciences and Technology (QST) and Kobe University in Japan, led this innovative research. ■ The Link Between Enzyme Hydrolysis and Quantum Tunneling The research team utilized deuterium, an isotope of hydrogen, to track how quantum tunneling is involved in enzymatic chemical reactions. In a heavy deuterium environment, the probability of quantum tunneling is significantly lower compared to light hydrogen, and the research team precisely measured the resulting kinetic isotope effects (KIE) and their temperature dependence. Experimental results proved that the quantum tunneling effect is deeply involved in in vitro hydrolysis reactions essential for cellular metabolism, such as SIRT3-mediated deacetylation, I-SceI-mediated DNA cleavage, and caspase-3-mediated protein cleavage, as evidenced by the disappearance of the isotope effect above specific temperatures. ■ A Halted DNA Repair System Furthermore, the research team directly investigated the impact of the quantum characteristics of these enzyme reactions on living cells. When human cells were exposed to a deuterium-substituted (D₂O) medium environment that artificially lowered the probability of quantum tunneling, it was observed that DNA homologous recombinational (HR) repair, one of the core survival mechanisms of cells, was almost completely inhibited. This means that the most important biochemical repair process protecting and maintaining the genetic information of organisms undergoes a chain reaction of several enzymes and cannot function normally without quantum tunneling phenomena. ■ Quantum Effects Dominating Cell Viability This study empirically demonstrates that core biochemical reactions in living organisms do not simply rely on thermodynamic energy but are fundamentally indebted to quantum mechanical tunneling phenomena. The discovery that numerous hydrolysis and repair reactions performed by enzymes within cells are ultimately strictly dominated by quantum effects serves as crucial evidence that rewrites life phenomena from a purely quantum physics perspective. https://www.biorxiv.org/content/10.1101/2023.07.18.549596v1
• A study published in the international journal Communications Physics demonstrated the phenomenon of proton tunneling inside DNA utilizing an open quantum systems approach. • The research confirmed that protons within DNA hydrogen bonds pass through binding barriers via quantum tunnelling, going well beyond simple thermal fluctuations, and that this plays a dominant role in the conversion of base pairs into rare tautomers. • This is a groundbreaking result proving that the fundamental genetic mutation process of life is driven by microscopic quantum tunneling probabilities, revealing that tautomeric states can induce natural point mutations. [Quantum Biology Society] The DNA double helix, which contains all the genetic information of living organisms, is stably maintained by hydrogen bonds between base pairs. However, even in this robust structure, unexplained point mutations occasionally occur, becoming the seeds of evolution and disease. Recently, a study demonstrating that quantum tunnelling—a bizarre physical law of the subatomic world—is deeply involved behind this fundamental biological phenomenon was published, surprising both the biology and physics communities. The paper detailing this groundbreaking discovery, titled "An open quantum systems approach to proton tunnelling in DNA," was made freely available in Communications Physics, a sister journal to the world-renowned Nature. A research team consisting of Louie Slocombe, Marco Sacchi, and Jim Al-Khalili from the University of Surrey in the UK led this interdisciplinary study. ■ The Power of Quantum Tunneling Beyond Classical Chemistry From the perspective of general classical biochemistry, it has been assumed that for protons forming DNA hydrogen bonds to change positions, sufficient thermal fluctuation is required to overcome the binding barrier. However, the researchers discovered a surprising fact through an open quantum systems model that precisely reflects the effects of decoherence and dissipation within the cellular environment. Protons instantly change their binding positions through quantum tunneling, passing through the barrier despite a lack of energy, and the contribution of quantum tunneling to the chemical reaction rate is several orders of magnitude larger than classical over-the-barrier hopping. ■ The Beginning of Mutation: Tautomeric Conversion According to the analysis, this quantum tunneling plays a dominant role in the conversion of Guanine-Cytosine (G-C) base pairs from their canonical form into highly rare and unstable tautomeric forms. The problem arises when the DNA strands are separated by the helicase enzyme and replication occurs in this state. The research team confirmed that at biological temperatures (around 300K), the thermal equilibrium occupation probability of the tautomer reaches an astoundingly high value of 1.73 × 10⁻⁴. This is significantly higher than the previously known natural spontaneous mutation rate (about 10⁻⁸), strongly suggesting that tautomerisation via quantum tunneling is a substantial and crucial cause of point mutations. ■ Presenting a New Paradigm in Life Sciences This study is a monumental achievement proving that genetic stability and the mutation process—the most fundamental and secretive domain of life—are not accidental chemical mistakes but are directly driven by the probability of quantum tunneling, a physical law of the microscopic world. This is a powerful demonstration that overturns the conventional view of interpreting biological phenomena solely through macroscopic molecular structures and chemical bonds, showing that quantum mechanics can be the key to fully explaining genetic mutation models.
• Published in Nature's sister journal Communications Physics, proposing an 'open quantum systems approach to proton tunnelling in DNA'. • Analysis of G-C base pairs confirmed that the proton transfer rate by tunnelling is overwhelmingly higher than classical methods even at biological temperatures and in a dissipative environment. • Demonstrated a high tautomeric occupation probability... suggesting that DNA mutation is deeply governed by quantum mechanical processes. [Quantum Biology Society] Research revealing that the fundamental cause of mutations threatening the genetic stability of DNA—the core of life preservation—is based on quantum mechanical phenomena rather than classical biochemical reactions is drawing significant attention from the academic community. A paper published in Communications Physics, a sister journal of Nature, titled "An open quantum systems approach to proton tunnelling in DNA" verified this innovative hypothesis with a sophisticated physical model. A joint research team, including Louie Slocombe and Professor Jim Al-Khalili, thoroughly analyzed the quantum mechanical processes related to proton transfer. ■ Protons Piercing Through Hydrogen Bonds, Inducing 'Point Mutations' If a proton moves out of its orbit within the hydrogen bonds of the Guanine-Cytosine (G-C) base pair connecting the DNA double helix structure, tautomerisation occurs, altering the chemical structure of the base, which can lead to a point mutation, an error in genetic information. However, exactly how this process occurs in a warm and complex biological environment has long been a matter of debate. To solve this challenge, the research team applied an open quantum system that integrated an accurate structural model of the G-C base pair with the quantum dynamics of the hydrogen bond proton and the influence of the decoherent and dissipative cellular environment. ■ Quantum Effects Surviving Even in Biological Environments... "Tens of Thousands of Times Faster Than Over-the-Barrier Hopping" The analysis results completely overturned the conventional wisdom that quantum phenomena are confined only to the microscopic world or cryogenic temperatures. The research team found that, despite biological temperatures and environmental factors, the quantum tunnelling contribution to the proton transfer rate is several orders of magnitude (tens of thousands of times) larger than the classical 'over-the-barrier hopping' method, where particles gain energy to cross the barrier. Due to the strong quantum tunnelling effect, the canonical and tautomeric forms of the G-C base pair inter-convert over timescales far shorter than biological ones and very rapidly reach thermal equilibrium. ■ The Origins of Cancer and Evolution Lie in Quantum Probabilities What is even more surprising is that the tautomeric occupation probability through tunnelling reaches a significant level of 1.73 × 10⁻⁴. This suggests that such proton transfer may well play a far more dominant and important role in DNA mutation than the academic community has hitherto thought. This study, which proves that DNA mutations—the macroscopic consequences driving the onset of genetic diseases or cancer, and further, the evolution of life—are in fact thoroughly governed by microscopic quantum tunnelling phenomena, will serve as a powerful indicator of how Quantum Biology can innovate the paradigms of medicine and genetics in the future.
BACKGROUND: Key biological processes underlying health and disease-including electron transfer, redox regulation, and radical-mediated signaling-are fundamentally governed by quantum-mechanical principles. These processes are central to mitochondrial function, metabolism, and cellular signaling, yet their biomedical implications have remained difficult to address using classical computational approaches. RATIONALE: Recent advances in quantum computing, quantum sensing, and quantum machine learning enable direct simulation and measurement of quantum phenomena in biologically relevant systems. Hybrid quantum-classical algorithms, such as the Variational Quantum Eigensolver and Quantum Phase Estimation, now provide first-principles access to redox potentials, electronic couplings, and spin-dependent reactions that are directly linked to disease mechanisms. These developments establish the foundation for quantum biomedicine as a translational framework bridging molecular physics and clinical medicine. CONTENT: This review synthesizes current progress in the application of quantum technologies to biomedicine, emphasizing translational relevance. We discuss quantum-informed modeling of cancer metabolism and redox rewiring, protein misfolding in neurodegenerative diseases, immune and inflammatory signaling, infectious disease mechanisms, and drug discovery. We further propose a Quantum-Experimental-Clinical (QEC) pipeline that integrates quantum simulations with experimental validation and multi-omics clinical data, enabling mechanistic interpretation of disease phenotypes and identification of redox- and spin-sensitive therapeutic targets. CONCLUSION: Quantum biomedicine introduces a new mechanistic layer that links electronic-scale processes to clinical phenotypes. While current implementations are constrained by NISQ-era hardware, rapid advances in quantum algorithms and sensing technologies position quantum approaches as emerging tools in precision and translational medicine. Strategic integration of quantum methods with experimental and clinical workflows may accelerate biomarker discovery and therapeutic development. KEY POINTS: Quantum biomedicine redefines life as a dynamic equilibrium sustained by quantum coherence, tunnelling and redox resonance. Hybrid quantum-classical algorithms, such as VQE and QPE, enable first-principles modelling of redox and spin-dependent reactions with near-experimental accuracy. NISQ-era hardware supports proof-of-concept simulations of electron tunnelling and radical-pair dynamics, bridging computation with measurable biophysics. Integration of quantum simulations with spectroscopy and cryo-EM establishes a quantum-experimental-clinical (QEC) pipeline linking theory, experiment and medicine. Ethical, educational and governance frameworks are essential for equitable, transparent and sustainable implementation of quantum health technologies.